The new MHRA’s framework for clinical studies By Giuliana Miglierini The repositioning of the United Kingdom as a global leader for clinical development of medicinal…
How to approach drug substance supply in new product introduction (NPI) processes by Giuliana Miglierini A key issue to be faced during pharmaceutical development refers to the supply of the…